The Government Pharmaceutical Organization (GPO) joins with many sectors to respond to the effect of the Covid-19 that affects drug manufacturing, estimated that not more than 1 month will have severe shortage. As well as suggesting ways to solve the problem for the government so that other chronic disease patients will continuously have sufficient medication. Especially diabetes and high blood pressure patients that need to take medication and some cases must take medication continuously. The GPO has stated that problems regarding accessibility of chronic disease drugs is an urgent issue that needs immediate resolution, as does the administration of medication list for Covid-19. Otherwise, this will definitely cause chaos for the medicine room and patients.